MeVis Medical Solutions AG Cash Flow Conversion Efficiency
MeVis Medical Solutions AG cash flow conversion efficiency. Based on the latest financial reports, MeVis Medical Solutions AG (M3V) has a cash flow conversion efficiency ratio of 0.005x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€96.63K ≈ $112.97K USD) by net assets (€17.83 Million ≈ $20.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of MeVis Medical Solutions AG (2006–2025)
Cash flow conversion efficiency of MeVis Medical Solutions AG from 2006 to 2025. This chart illustrates how MeVis Medical Solutions AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MeVis Medical Solutions AG stock quote for real-time trading data and today's change.
MeVis Medical Solutions AG Cash Flow Conversion Ratio Explained
MeVis Medical Solutions AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
MeVis Medical Solutions AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MeVis Medical Solutions AG ranked by their cash flow conversion efficiency. Also see MeVis Medical Solutions AG market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OS Therapies Incorporated
NYSE MKT:OSTX
|
-1.000x |
|
SKB Shutters Corporation Bhd
KLSE:7115
|
0.042x |
|
Synergetic Auto Performance Public Company Limited
BK:ASAP
|
1.134x |
|
Entertainment Network (India) Limited
NSE:ENIL
|
-0.015x |
|
Oceanpal Inc
NASDAQ:OP
|
-0.007x |
|
Australian Vanadium Ltd
AU:AVL
|
-0.040x |
|
Adaptimmune Therapeutics plc
F:473A
|
0.490x |
|
Arizona Gold & Silver Inc.
V:AZS
|
-0.042x |
Annual Cash Flow Conversion Efficiency for MeVis Medical Solutions AG (2006–2025)
The table below shows the annual cash flow conversion efficiency of MeVis Medical Solutions AG from 2006 to 2025. Review cash generation quality of MeVis Medical Solutions AG to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €17.83 Million ≈ $20.84 Million |
€3.88 Million ≈ $4.54 Million |
0.218x | +23.29% |
| 2024-09-30 | €17.83 Million ≈ $20.84 Million |
€3.15 Million ≈ $3.68 Million |
0.177x | -46.25% |
| 2023-09-30 | €17.83 Million ≈ $20.84 Million |
€5.85 Million ≈ $6.84 Million |
0.328x | +20.52% |
| 2022-09-30 | €17.83 Million ≈ $20.84 Million |
€4.86 Million ≈ $5.68 Million |
0.272x | -46.80% |
| 2021-09-30 | €17.83 Million ≈ $20.84 Million |
€9.13 Million ≈ $10.68 Million |
0.512x | +215.97% |
| 2020-09-30 | €17.83 Million ≈ $20.84 Million |
€2.89 Million ≈ $3.38 Million |
0.162x | -55.84% |
| 2019-09-30 | €17.83 Million ≈ $20.84 Million |
€6.54 Million ≈ $7.65 Million |
0.367x | +113.19% |
| 2018-09-30 | €32.06 Million ≈ $37.48 Million |
€5.52 Million ≈ $6.45 Million |
0.172x | -23.55% |
| 2017-09-30 | €32.51 Million ≈ $38.01 Million |
€7.32 Million ≈ $8.56 Million |
0.225x | +111.15% |
| 2016-09-30 | €32.89 Million ≈ $38.45 Million |
€3.51 Million ≈ $4.10 Million |
0.107x | -45.32% |
| 2015-09-30 | €33.73 Million ≈ $39.43 Million |
€6.58 Million ≈ $7.69 Million |
0.195x | +22.25% |
| 2014-09-30 | €30.27 Million ≈ $35.39 Million |
€4.83 Million ≈ $5.65 Million |
0.160x | -43.60% |
| 2013-09-30 | €26.45 Million ≈ $30.92 Million |
€7.48 Million ≈ $8.75 Million |
0.283x | +21.84% |
| 2012-09-30 | €22.77 Million ≈ $26.62 Million |
€5.29 Million ≈ $6.18 Million |
0.232x | -5.73% |
| 2011-09-30 | €20.73 Million ≈ $24.23 Million |
€5.11 Million ≈ $5.97 Million |
0.246x | +23.38% |
| 2010-09-30 | €24.79 Million ≈ $28.98 Million |
€4.95 Million ≈ $5.79 Million |
0.200x | +112.02% |
| 2009-09-30 | €32.61 Million ≈ $38.12 Million |
€3.07 Million ≈ $3.59 Million |
0.094x | +5.62% |
| 2008-09-30 | €32.61 Million ≈ $38.13 Million |
€2.91 Million ≈ $3.40 Million |
0.089x | +211.17% |
| 2007-09-30 | €30.77 Million ≈ $35.97 Million |
€-2.47 Million ≈ $-2.89 Million |
-0.080x | -104.63% |
| 2006-09-30 | €2.65 Million ≈ $3.10 Million |
€4.59 Million ≈ $5.37 Million |
1.732x | -- |
About MeVis Medical Solutions AG
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also of… Read more